Latest news with #NasdaqCompliance
Yahoo
05-08-2025
- Automotive
- Yahoo
Is Opendoor Technologies the Next Carvana?
Is Opendoor About to Have Its 'Carvana Moment'? Opendoor Technologies Company Overview Founded a little more than a decade ago in San Francisco, California, Zacks Rank #3 (Hold) stock Opendoor Technologies (OPEN) is a real estate development company that makes instant cash offers (known as an 'iBuyer') mainly in the residential real estate market. Opendoor leverages a technology-driven platform to find and make offers, purchasing the real estate directly from sellers. Opendoor then makes all the necessary upgrades, renovations, and repairs to relist and sell the real estate for a higher price (the average hold time is ~90 days). In addition to its real estate investment services, the company launched a mortgage services and home loan business. OPEN, which merged with Chamath Palihapitiya's Social Capital Hedosophia Holdings Corp II in 2020, also has a partnership with Redfin. This leading technology-driven real estate brokerage website competes with Zillow Group (ZG). OPEN: Shades of 2023 Carvana? Eric Jackson, founder of EMJ Capital, helped drum up interest in OPEN in July by comparing it to online car website Caravana (CVNA). The comparison resonates with me because the two companies share several similarities, including: · Beaten-down, Turnaround Plays: Carvana's multi-bag stock move started with a company on the brink of collapse. However, several bullish catalysts began to emerge. For OPEN, the company will benefit from lower interest rates, which will likely wake up a sleepy real estate market (betting website PolyMarket gives a 71% chance of an interest rate cut in September). · Digitizing Legacy Markets: Carvana allowsusers to buy or sell cars online, making a normally tedious process much more efficient and enjoyable. Opendoor is doing a similar model for the real estate market. · Meme Stock Cult Following: Similar to CVNA, OPEN is a favorite among retail investors on the wildly popular Reddit (RDDT) message board 'Wall Street Bets.' The surge in Robinhood (HOOD) stock illustrates that retail investors are again interested in trading, potentially suggesting sustained interest in OPEN shares OPEN Regains Nasdaq Compliance OPEN shares rose Monday and broke out of a bull flag pattern on heavy volume (accumulation) after the company announced that it had successfully regained compliance with the Nasdaq's minimum bid price requirement, sustaining a closing bid price of at least $1.00 for 12 consecutive trading sessions. Image Source: TradingView OPEN: Bullish Call Flow & Heavy Short Interest Could Provide Upside Fuel OPEN shares have experienced heavy buying in far out-of-the-money call options over the past few months – a bullish sign. Additionally, 40 million shares or ~38% of the OPEN share float are short. Should the stock keep rising, shorts will be forced to cover, potentially triggering a GameStop (GME)-Esque short squeeze. Bottom Line Opendoor Technologies presents a compelling, albeit speculative investment case. The company may benefit from lower interest rates, the continued digitization of the real estate market, and high short interest. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GameStop Corp. (GME) : Free Stock Analysis Report Opendoor Technologies Inc. (OPEN) : Free Stock Analysis Report Zillow Group, Inc. (ZG) : Free Stock Analysis Report Carvana Co. (CVNA) : Free Stock Analysis Report Robinhood Markets, Inc. (HOOD) : Free Stock Analysis Report Reddit Inc. (RDDT) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
National Post
14-07-2025
- Business
- National Post
ImmunoPrecise Regains Compliance with Nasdaq Minimum Bid Price Requirement
Article content AUSTIN, Texas — ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ('IPA' or the 'Company'), a company operating at the convergence of TechBio and biological intelligence, today announced that it has received formal notification from The Nasdaq Stock Market LLC ('Nasdaq') confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), concerning the minimum bid price requirement. Article content The notice, dated July 11, 2025, stated that for the 10 consecutive business days from June 26, 2025, through July 10, 2025, the closing bid price of the Company's common shares was at or above $1.00 per share. As a result, ImmunoPrecise has satisfied the requirements for continued listing on the Nasdaq Capital Market, and the matter is now closed. Article content Article content 'This compliance milestone reflects the growing recognition of our evolution into a platform company built around bio-native AI,' said Dr. Jennifer Bath, CEO of ImmunoPrecise. 'We're building the digital infrastructure that connects biological complexity with real-world impact – enabling new possibilities in therapeutic development and beyond. The recent momentum in our share price is a strong signal of support for that vision.' Article content Through its proprietary LENS ai™ platform powered by HYFT ® technology, ImmunoPrecise is reimagining how biological data can be modeled and deployed at scale. The LENS ai platform is transforming therapeutic discovery from a decades-long process to rapid, precision-guided development by systematically identifying the most promising therapeutic pathways through integration of sequence, structure, literature and functional data across the entire biosphere. Article content Our integrated framework enables unprecedented zero-shot discovery scenarios where LENS ai predicts therapeutic interactions for completely novel targets, demonstrated through recent validation across 17 previously unseen antibody-protein complexes, achieving near-crystallography precision without prior training data. This unique bio-native AI approach captures functional meaning rather than structural patterns, enabling new capabilities across R&D from drug and vaccine discovery to systems biology and positioning IPA at the frontier of TechBio innovation. Article content About ImmunoPrecise Antibodies Ltd. Article content ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is advancing Bio-Native™ AI at the intersection of biology and computation. The Company's LENSai™ and HYFT ® platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering next-generation workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. Article content Forward-Looking Statements Article content This press release contains forward-looking statements within the meaning of applicable United States and Canadian securities laws. Forward-looking statements are often identified by words such as 'expects,' 'intends,' 'plans,' 'anticipates,' 'believes,' or similar expressions, or by statements that certain actions, events, or results 'may,' 'will,' 'could,' or 'might' occur or be achieved. These statements include, but are not limited to, statements regarding the Company's strategic direction, the Company's future growth, its ability to execute on its scientific, commercial, and capital markets initiatives, and the continued evolution of its leadership and business strategy. Article content Forward-looking statements are based on management's current expectations, assumptions, and projections about future events. Actual results may differ materially from those expressed or implied due to a variety of factors, many of which are beyond the Company's control. These factors include, but are not limited to, changes in board or executive leadership; shifts in strategic priorities; scientific or operational challenges; evolving market and economic conditions; changes in regulatory environments; the pace of innovation in AI and biotechnology; and other risks inherent to the Company's industry and business model. Article content Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied herein. Additional information regarding risks and uncertainties is included in the Company's Annual Report on Form 20-F, as amended, for the fiscal year ended April 30, 2024, available on the Company's SEDAR+ profile at and EDGAR profile at Should any of these risks materialize, actual results could vary significantly from those currently anticipated. Article content Article content Article content Article content Article content Article content Article content
